Expression of functional folate receptors in multiple myeloma

References

• Mehra NK, Mishra V, Jain NK. Receptor-based targeting of therapeutics. Ther Deliv. 2013;4:369–394.
   PubMedGoogle Scholar
• Bai M, Bornhop DJ. Recent advances in receptor-targeted fluorescent probes for in vivo cancer imaging. Curr Med Chem. 2012;19:4742–4758.
   PubMed Web of Science ®Google Scholar
• Zhao R, Diop-Bove N, Visentin M, et al. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr. 2011;31:177–201.
   PubMed Web of Science ®Google Scholar
• Yang J, Vlashi E, Low P. Folate-linked drugs for the treatment of cancer and inflammatory diseases. Subcell Biochem. 2012;56:163–169.
   PubMedGoogle Scholar
• Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol. 2009;13:256–262.
   PubMed Web of Science ®Google Scholar
• Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 2014;17:89–95.
   PubMed Web of Science ®Google Scholar
• Ledermann JA, Canevari S, Thigpen T. Targeting the folate receptor: diagnostic and therapeutic approaches to personalized cancer treatments. Ann Oncol. 2015;26:2034–2043.
   PubMed Web of Science ®Google Scholar
• Sega EI, Low PS. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev. 2008;27:655–664.
   PubMed Web of Science ®Google Scholar
• Teng L, Xie J, Teng L, et al. Clinical translation of folate receptor-targeted therapeutics. Expert Opin Drug Deliv. 2012;9:901–908.
   PubMed Web of Science ®Google Scholar
• Marchetti C, Palaia I, Giorgini M, et al. Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review. Onco Targets Ther. 2014;7:1223–1236.
   PubMed Web of Science ®Google Scholar
• Lorusso PM, Edelman MJ, Bever SL, et al. Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors. J Clin Oncol. 2012;30:4011–4016.
   PubMed Web of Science ®Google Scholar
• Fisher RE, Siegel BA, Edell SL, et al. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med. 2008;49:899–906.
   PubMed Web of Science ®Google Scholar
• Konner JA, Bell-McGuinn KM, Sabbatini P, et al. Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study. Clin Cancer Res. 2010;16:5288–5295.
   PubMed Web of Science ®Google Scholar
• Naumann RW, Coleman RL, Burger RA, et al. PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer. J Clin Oncol. 2013;31:4400–4406.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, White AJ, Weil SC, et al. Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer. Gynecol Oncol. 2013;129:452–458.
   PubMed Web of Science ®Google Scholar
• Wang H, Zheng X, Behm FG, et al. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia. Blood. 2000;96:3529–3536.
   PubMed Web of Science ®Google Scholar
• Hao H, Qi H, Ratnam M. Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites. Blood. 2003;101:4551–4560.
   PubMed Web of Science ®Google Scholar
• Li H, Lu Y, Piao L, et al. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation of all-trans retinoic acid. Int J Pharm. 2010;402:57–63.
   PubMedGoogle Scholar
• Xu Y, Wang T, Tang R, et al. All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells. Tumor Biol. 2010;31:589–595.
   PubMedGoogle Scholar
• Iwakiri S, Sonobe M, Nagai S, et al. Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol. 2008;15:889–899.
   PubMed Web of Science ®Google Scholar
• Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res. 2008;41:120–129.
   PubMed Web of Science ®Google Scholar
• O’Shannessy DJ, Somers EB, Wang LC, et al. Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers. J Ovarian Res. 2015;8:29.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Nymoen DA, Dong HP, et al. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions. Hum Pathol. 2009;40:1453–1460.
   PubMed Web of Science ®Google Scholar
• Shia J, Klimstra DS, Nitzkorski JR, et al. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Hum Pathol. 2008;39:498–505.
   PubMed Web of Science ®Google Scholar
• Hartmann LC, Keeney GL, Lingle WL, et al. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer. 2007;121:938–942.
   PubMed Web of Science ®Google Scholar
• O’Shannessy DJ, Yu G, Smale R, et al. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. Oncotarget. 2012;3:414–425.
   PubMed Web of Science ®Google Scholar
• Saba NF, Wang X, Muller S, et al. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head Neck. 2009;31:475–481.
   PubMed Web of Science ®Google Scholar
• Christoph DC, Reyna-Asuncion B, Hassan B, et al. Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients. Clin Lung Cancer. 2014;15:320–330.
   PubMed Web of Science ®Google Scholar
• Köbel M, Madore J, Ramus SJ, et al. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An ovarian tumour tissue analysis consortium study. Br J Cancer. 2014;111:2297–2307.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Tacha DE, et al. Folate receptor α associated with triple-negative breast cancer and poor prognosis. Arch Pathol Lab Med. 2014;138:890–895.
   PubMed Web of Science ®Google Scholar
• Shen J, Putt KS, Visscher DW, et al. Assessment of folate receptor-β expression in human neoplastic tissues. Oncotarget. 2015;6:14700–14709.
   PubMedGoogle Scholar
• Pan XQ, Zheng X, Shi G, et al. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood. 2002;100:594–602.
   PubMed Web of Science ®Google Scholar
• Ross JF, Wang H, Behm FG, et al. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer. 1999;85:348–357.
   PubMed Web of Science ®Google Scholar
• Childress MO, Dhawan D, Leamon CP, et al. Assessment of folate receptor expression and folate uptake in multicentric lymphomas in dogs. Am J Vet Res. 2014;75:187–194.
   PubMed Web of Science ®Google Scholar
• O’Connell FP, Pinkus JL, Pinkus GS. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol. 2004;121:254–263.
   PubMed Web of Science ®Google Scholar
• Saul JM, Annapragada A, Natarajan JV, et al. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 2003;92:49–67.
   PubMed Web of Science ®Google Scholar
• Reddy JA, Haneline LS, Srour EF, et al. Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. Blood. 1999;93:3940–3948.
   PubMed Web of Science ®Google Scholar
• Lynn RC, Poussin M, Kalota A, et al. Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood. 2015;125:3466–3476.
   PubMed Web of Science ®Google Scholar